Skip to content

The effect of mechanical power-guided ventilation versus traditional lung protective ventilation strategy on the risk of post-operative pulmonary complications in gerontal patients undergoing thoracoscopic lobectomy —— A randomized controlled trail

Mechanical power-guided ventilation versus traditional lung protective ventilation strategy on the risk of post-operative pulmonary complications in gerontal patients undergoing thoracoscopic lobectomy —— A randomized controlled trail.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076892
Enrollment
Unknown
Registered
2023-10-23
Start date
2023-10-25
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pulmonary complications

Interventions

control group:The ventilation mode was adjusted to volume-controlled ventilation (VCV), and PEEP was constant at 5cmH2O
experiment group:The ventilation mode was adjusted to volumecontrolled ventilation (VCV) mode. PEEP was gradually decreased from 14 cmH2O to 2cmH2O, and each titration level was maintained for 6 respi

Sponsors

The affiliated hospital of Southewest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: Select patients who underwent video assisted thoracoscopic surgery (VATS) lobectomy for lung cancer in our hospital. (1) Patients who are aware of and agree to participate in the clinical observation; (2) Age greater than 60 but less than 80; (3) ASA classification<Level III; (4) No tumor metastasis was found before surgery, and no relevant surgery or chemotherapy was received; (5) There were no significant abnormalities in cardiopulmonary function before surgery, and liver and kidney function were basically normal.

Exclusion criteria

Exclusion criteria: (1) Emergency surgery; (2) Preoperative complications include acute lung injury, pulmonary bullae, severe bronchiectasis, and uncontrolled asthma, Silicosis, pleural effusion, empyema, pleural or chest wall disease, and forced expiratory volume (FEV1) less than 60% in 1 second after inhalation, as well as acute respiratory distress syndrome or respiratory failure three months before surgery and a history of previous lung surgery; (3) Critically ill patients, including liver dysfunction (liver failure or Child Pugh score of B or C); Chronic renal failure (glomerular filtration rate2); (4) Patients with contraindications for nerve block (severe coagulation dysfunction, spinal deformities, systemic or local infections); (5) Difficult airway or intubation; (6) Neuropsychiatric disorders, elderly dementia, psychological disorders.

Design outcomes

Primary

MeasureTime frame
postoperative pulmonary complications;

Secondary

MeasureTime frame
End-inspiratory lung volume on the ventilated side;hospital stay;MP distribution during one-lung ventilation;Expression levels of inflammatory factors related to lung injury;

Countries

China

Contacts

Public ContactYingying Zhang

The affiliated hospital of Southewest Medical University

yingyingzhang917@gmail.com+86 189 8279 6195

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026